Back to Search
JAMES ZHOU, MD
MD
Internal Medicine Physician
NPI: 1720512692IndividualAccepts Medicare
Specialties, Licenses & Credentials
Addiction Medicine (Internal Medicine) Physician
Internal Medicine — Addiction Medicine
Code: 207RA0401X
286904(MA)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
286904(MA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2017
Research & Publications (20)
Polycystins and primary cilia: primers for cell cycle progression.
PMID 19572811·Annu Rev Physiol·2009
6-review
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.
PMID 19347029·Oncogene·2009
8-other
Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis.
PMID 17998392·J Exp Med·2007
7-preclinical
Symposium introduction: metabolic syndrome and the onset of cancer.
PMID 18265474·Am J Clin Nutr·2007
8-other
Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice.
PMID 18265483·Am J Clin Nutr·2007
7-preclinical
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.
PMID 17485550·Blood·2007
4-observational
gp49B1 deficiency is associated with increases in cytokine and chemokine production and severity of proliferative synovitis induced by anti-type II collagen mAb.
PMID 15827966·Eur J Immunol·2005
7-preclinical
The role of the tumor microenvironment in hematological malignancies and implication for therapy.
PMID 15769648·Front Biosci·2005
6-review
Soy and the prevention of lifestyle-related diseases.
PMID 15649276·Clin Exp Pharmacol Physiol·2004
6-review
Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.
PMID 14618609·Int J Cancer·2004
7-preclinical
Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations.
PMID 15170660·Int J Cancer·2004
7-preclinical
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
PMID 12566493·J Nutr·2003
7-preclinical
Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils.
PMID 14557414·J Exp Med·2003
7-preclinical
Regional upregulation of Kv2.1-encoded current, IK,slow2, in Kv1DN mice is abolished by crossbreeding with Kv2DN mice.
PMID 12529256·Am J Physiol Heart Circ Physiol·2003
7-preclinical
Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
PMID 12242729·Prostate·2002
7-preclinical
Acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized chinese women: a randomized controlled trial.
PMID 19189989·Evid Based Complement Alternat Med·2011
8-other
Assessment of perihematomal hypoperfusion injury in subacute and chronic intracerebral hemorrhage by CT perfusion imaging.
PMID 19660194·Neurol Res·2010
8-other
IFN regulatory factor 8 regulates MDM2 in germinal center B cells.
PMID 19648273·J Immunol·2009
7-preclinical
Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRbeta/IRS-1 and Akt.
PMID 19682478·Toxicol Appl Pharmacol·2009
7-preclinical
The incorporation of chlorhexidine in a two-step self-etching adhesive preserves dentin bond in vitro.
PMID 19615807·J Dent·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 55 FRUIT ST # 1500
BOSTON, MA 02114 - Phone
- (617) 724-3874
Quick Facts
- NPI
- 1720512692
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile